78 related articles for article (PubMed ID: 10099113)
1. Endogenous mucosal antiviral factors of the oral cavity.
Shugars DC
J Infect Dis; 1999 May; 179 Suppl 3():S431-5. PubMed ID: 10099113
[TBL] [Abstract][Full Text] [Related]
2. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
[TBL] [Abstract][Full Text] [Related]
3. Salivary Antiviral and Antibacterial Properties in the Encounter of SARS-CoV-2.
Mohtasham N; Bargi R; Farshbaf A; Shahri MV; Hesari KK; Mohajertehran F
Curr Pharm Des; 2023; 29(27):2140-2148. PubMed ID: 37670699
[TBL] [Abstract][Full Text] [Related]
4. Oral transmission of HIV, reality or fiction? An update.
Campo J; Perea MA; del Romero J; Cano J; Hernando V; Bascones A
Oral Dis; 2006 May; 12(3):219-28. PubMed ID: 16700731
[TBL] [Abstract][Full Text] [Related]
5. The initial interplay between HIV and mucosal innate immunity.
Caputo V; Libera M; Sisti S; Giuliani B; Diotti RA; Criscuolo E
Front Immunol; 2023; 14():1104423. PubMed ID: 36798134
[TBL] [Abstract][Full Text] [Related]
6. Salivary immunity of elite collegiate American football players infected with SARS-CoV-2 normalizes following isolation.
Granger J; Cho E; Lindsey K; Lemoine N; Calvert D; Marucci J; Mullenix S; O'Neal H; Irving BA; Johannsen N; Spielmann G
Sci Rep; 2022 May; 12(1):9090. PubMed ID: 35641582
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of respiratory microdroplet nuclei on common substrates.
Kosmidis-Papadimitriou A; Qi S; Squillace O; Rosik N; Bale M; Fryer PJ; Zhang ZJ
Interface Focus; 2022 Feb; 12(1):20210044. PubMed ID: 34956611
[TBL] [Abstract][Full Text] [Related]
8. Salivary Protein Roles in Oral Health and as Predictors of Caries Risk.
Laputková G; Schwartzová V; Bánovčin J; Alexovič M; Sabo J
Open Life Sci; 2018 Jan; 13():174-200. PubMed ID: 33817083
[TBL] [Abstract][Full Text] [Related]
9. HIV and SIV in Body Fluids: From Breast Milk to the Genitourinary Tract.
Kordy K; Tobin NH; Aldrovandi GM
Curr Immunol Rev; 2019; 15(1):139-152. PubMed ID: 33312088
[TBL] [Abstract][Full Text] [Related]
10. Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection.
Nelson CS; Fouda GGA; Permar SR
Curr Immunol Rev; 2019; 15(1):131-138. PubMed ID: 33223981
[TBL] [Abstract][Full Text] [Related]
11. A to Z of Zika Virus: A Comprehensive Review for Clinicians.
Arora HS
Glob Pediatr Health; 2020; 7():2333794X20919595. PubMed ID: 32529004
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.
Ikeno R; Yamada E; Yamazaki S; Ueda T; Nagata M; Takagi R; Kato S
J Int Med Res; 2018 Mar; 46(3):996-1007. PubMed ID: 29119839
[TBL] [Abstract][Full Text] [Related]
13. Oropharyngeal mucosal transmission of Zika virus in rhesus macaques.
Newman CM; Dudley DM; Aliota MT; Weiler AM; Barry GL; Mohns MS; Breitbach ME; Stewart LM; Buechler CR; Graham ME; Post J; Schultz-Darken N; Peterson E; Newton W; Mohr EL; Capuano S; O'Connor DH; Friedrich TC
Nat Commun; 2017 Aug; 8(1):169. PubMed ID: 28765581
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Infective Zika Virus from Urine and Saliva of Patients in Brazil.
Bonaldo MC; Ribeiro IP; Lima NS; Dos Santos AA; Menezes LS; da Cruz SO; de Mello IS; Furtado ND; de Moura EE; Damasceno L; da Silva KA; de Castro MG; Gerber AL; de Almeida LG; Lourenço-de-Oliveira R; Vasconcelos AT; Brasil P
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004816. PubMed ID: 27341420
[TBL] [Abstract][Full Text] [Related]
15. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
[TBL] [Abstract][Full Text] [Related]
16. Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity.
Wahl A; Baker C; Spagnuolo RA; Stamper LW; Fouda GG; Permar SR; Hinde K; Kuhn L; Bode L; Aldrovandi GM; Garcia JV
J Virol; 2015 Nov; 89(21):10868-78. PubMed ID: 26292320
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cystatin C activities against HIV.
Vernekar V; Velhal S; Bandivdekar A
Indian J Med Res; 2015 Apr; 141(4):423-30. PubMed ID: 26112843
[TBL] [Abstract][Full Text] [Related]
18. A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.
Romas LM; Hasselrot K; Aboud LG; Birse KD; Ball TB; Broliden K; Burgener AD
PLoS One; 2014; 9(6):e100820. PubMed ID: 24978053
[TBL] [Abstract][Full Text] [Related]
19. Human antimicrobial peptides and proteins.
Wang G
Pharmaceuticals (Basel); 2014 May; 7(5):545-94. PubMed ID: 24828484
[TBL] [Abstract][Full Text] [Related]
20. Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.
Pushpanshu K; Sathawane RS; Kaushik R
Indian J Palliat Care; 2014 Jan; 20(1):26-30. PubMed ID: 24600179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
